| Budget Amount *help |
¥43,290,000 (Direct Cost: ¥33,300,000、Indirect Cost: ¥9,990,000)
Fiscal Year 2019: ¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2018: ¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2017: ¥8,190,000 (Direct Cost: ¥6,300,000、Indirect Cost: ¥1,890,000)
Fiscal Year 2016: ¥24,440,000 (Direct Cost: ¥18,800,000、Indirect Cost: ¥5,640,000)
|
|---|
| Outline of Final Research Achievements |
Exosomes are extracellular vesicles and play an important role for cancer tumorigenesis, cancer progression, and cancer metastasis. And, exosomes have more information than conventional blood biomarkers. Recently, researchers expected exosomes as the next-generation cancer diagnosis biomarkers. In this research, we proposed a device to demonstrate rapid and precise analysis of cancer specific exosomes using nanospace unique features. And furthermore, we had a goal to aim for cancer diagnosis system, which could achieve higher speed and more accurate diagnosis than conventional systems.
|
